Comparative Reverse Screening Approach to Identify Potential Anti-neoplastic Targets of Saffron Functional Components and Binding Mode |
Bhattacharjee, Biplab
(Department of Biotechnology, PES Institute of Technology)
Vijayasarathy, Sandhya (Department of Biotechnology, PES Institute of Technology) Karunakar, Prashantha (Department of Biotechnology, PES Institute of Technology) Chatterjee, Jhinuk (Department of Biotechnology, PES Institute of Technology) |
1 | Thornalley PJ (2003). Glyoxalase I - structure, function and a critical role in the enzymatic defence against glycation. Biochem Soc Trans, 31, 1343-8. DOI |
2 | Trott O, Olson AJ (2010). AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. J Comput Chem, 31, 455-1. |
3 | Wang JC, Chu PY, Chen CM, et al (2012). idTarget: a webserver for identifying protein targets of small chemical molecules with robust scoring functions and a divide-and-conquer docking approach. Nucleic Acids Research, 40, 393-9. DOI |
4 | Yang R, Vernon K, Thomas A, et al (2011). Crocetin Reduces Activation of Hepatic Apoptotic Pathways and Improves Survival in Experimental Hemorrhagic Shock. JPEN J Parenter Enteral Nutr, 35, 107-3. DOI |
5 | Yanyan L, Tao Z, Duxin S (2009). New developments in Hsp90 inhibitors as anti-cancer therapeutics: mechanisms, clinical perspective and more potential. Drug Resist Updat, 12, 17-7. DOI ScienceOn |
6 | Yu XC, Miranda M, Liu Z, et al (2010). Novel potent inhibitors of deoxycytidine kinase identified and compared by multiple assays. J Biomol Screen, 15, 72-9. DOI |
7 | Zheng R, Chen TS, Lu T (2011). A Comparative Reverse Docking Strategy to Identify Potential Antineoplastic Targets of Tea Functional Components and Binding Mode. Int J Mol Sci, 12, 5200-12. DOI |
8 | Zhou CH, Xiang M, He SY, et al (2010). Protein kinase C pathway is involved in the inhibition by crocetin of vascular smooth muscle cells proliferation. Phytotherapy Res, 24, 1680-6. DOI |
9 | Abdullaev FI, Frenkel GD (1992). The effect of saffron on intracellular DNA, RNA and protein synthesis in malignant and non-malignant human cells. BioFactors, 4, 43-5. |
10 | Abdullaev FI, Gonzalez de Mejia E (1997). Antitumor effect of plant lectins. Natural Toxins, 5, 157-3. |
11 | Abdullaev FI, Gonzalez de Mejia E (1995-1996). Inhibition of colony formation of Hela cells by naturally occurring and synthetic agents. BioFactors, 5, 133-8. |
12 | Abdullaev FI, Riveron NL, Rotenburd BV, et al (2000). Saffron as chemopreventive agent. In: Wenyi T, Ed. Food of 21st century: food and resource technology environment. China: Ligth Industry Press, 185-5. |
13 | Abdullaev FI (1993). Biological effects of saffron. Biofactors, 4, 83-6. |
14 | Abdullaev FI (2002). Cancer chemopreventive and tumoricidal properties of saffron (Crocus sativus L.). Exp Biol Med Maywood, 227, 20-5. DOI |
15 | Abdullaev FI (1994). Inhibitory effect of crocetin on intracellular nucleic acid and protein synthesis in malignant cells. Toxicol Lett, 40, 243-1. |
16 | Amin A, Hamza AA, Bajbouj K, et al (2011). Saffron: a potential candidate for a novel anticancer drug against hepatocellular carcinoma. Hepatology, 1-46. |
17 | Chang VC, Lin YL, Lee MJ, et al (1996). Inhibitory effect of crocetin on benzo(a)pyrece genotoxicity and neoplastic transformation in C3H1OT1/2 cells. Anticancer Res, 765, 3603-8. |
18 | Chen YZ, Ung CY (2001). Prediction of potential toxicity and side effect protein targets of a small molecule by a ligandprotein inverse docking approach. J Mol Graph Model, 20, 199-18. DOI |
19 | Creighton DJ, Zheng ZB, Holewinski R, et al (2003). Glyoxalase I inhibitors in cancer chemotherapy. Biochem Soc Trans, 31, 1378-2. DOI |
20 | Chryssanthi DG, Dedes PG, Karamanos NK, et al (2011). Crocetin inhibits invasiveness of MDA-MB-231 breast cancer cells via downregulation of matrix metalloproteinases. Planta Med, 77, 146-1. DOI |
21 | Dufresne C, Cormier F, Dorion S (1997). In vitro formation of crocetin glucosyl esters by Crocus sativus callus extract. Planta Med, 63, 150-3. DOI ScienceOn |
22 | El Daly ES (1998). Protective effect of cysteine and vitamin E, Crocus sativus and Nigella sativa extracts on cisplatininduced toxicity in rats. J Pharm Belg, 53, 93-5. |
23 | Escribano J, Alonso GL, Coca-Prados M, et al (1996). Crocin, safranal and picocrocin from saffron (Crocus sativus L.) inhibit the growth of human cancer cells in vitro. Cancer Lett, 100, 23-30. DOI ScienceOn |
24 | Escribano J, Diaz-Guerra MJ, Riese HH, et al (1999). In vitro activation of macrophages from corms of Crocus sativus L. Cancer Lett, 144, 107-4. DOI |
25 | Escribano J, Diaz-Guerra MJ, Riese HH, et al (2000). The cytotoxic effect of glucoconjugate extracted from corms of saffron plant (Crocus sativus) on human cell lines in culture. Planta Med, 66, 157-2. DOI |
26 | Escribano J, Piqueras A, Medina J, et al (1999). Production of a cytotoxic proteoglycan using callus culture of saffron corms (Crocus sativus L.). J Biotechnol, 73, 53-9. DOI |
27 | Escribano J, Rios J, Fernandez JA (1999). Isolation and cytotoxic properties of novel glycoconjugate from corms of saffron plant (Crocus sativus L.). Biochim Biophys Acta, 1426, 217-22. DOI |
28 | Garcia-Olmo DC, Riese HH, Escribano J, et al (1999). Effects of long-term treatment of colon adenocarcinoma with crocin, a carotenoid from saffron (Crocus sativus L.): an experimental study in the rats. Nutr Cancer, 35, 120-6. DOI |
29 | Escribano J, Rubio A, Alvarez-Orti M, et al (2000). Purification and characterization of mannan-binding lectin specifically expressed in corms of saffron plant (Crocus sativus L.). J Agric Food Chem, 48, 457-3. DOI |
30 | Floryk D, Thompson TC (2008). Antiproliferative effects of AVN944, a novel inosine 5-monophosphate dehydrogenase inhibitor, in prostate cancer cells. Int J Cancer, 123, 2294-2. DOI |
31 | Hajduk PJ, Huth JR, Tse C (2005). Predicting protein druggability. Drug Discov Today, 10, 1675-82. DOI |
32 | Herman SEM, Gordon AL, Hertlein E, et al (2011). Tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765. Blood, 117, 6287-6. DOI ScienceOn |
33 | Hetschko H, Voss V, Senft C, et al (2008). BH3 mimetics reactivate autophagic cell death in anoxia-resistant malignant glioma cells. Neoplasia, 10, 873-85. DOI |
34 | Huang CM, Elmets CA, Tang DC, et al (2004). Proteomics reveals that proteins expressed during the early stage of Bacillus anthracis infection are potential targets for the development of vaccines and drugs. Genomics Proteomics Bioinforma, 3, 143-1. |
35 | Jones JO, Bolton EC, Huang Y, et al (2009). Non-competitive androgen receptor inhibition in vitro and in vivo. PNAS, 106, 7233-8. DOI |
36 | Kock N, Kasmieh R, Weissleder R, et al (2007). Tumor therapy mediated by lentiviral expression of shBcl-2 and S-TRAIL. Neoplasia, 9, 435-42. DOI |
37 | Liu X, Ouyang S, Yu B, et al (2010). PharmMapper Server: a web server for potential drug target identification via pharmacophore mapping approach. Nucleic Acids Res, 38, 609-14. DOI |
38 | Li H, Gao Z, Kang L, et al (2006). TarFisDock: a web server for identifying drug targets with docking approach. Nucleic Acids Res, 34, 219-24. DOI |
39 | Li R, Boehm AL, Miranda MB, et al (2007). Targeting antiapoptotic Bcl-2 family members with cell-permeable BH3 peptides induces apoptosis signaling and death in head and neck squamous cell carcinoma cells. Neoplasia, 9, 801-11. DOI |
40 | Lin JH, Lu AY (1997). Role of pharmacokinetics and metabolism in drug discovery and development. Pharmacol Rev, 49, 403-49. |
41 | Majewski S, Skopinska M, Marczak M, et al (1996). Vitamin D3 is a potent inhibitor of tumor cell-induced angiogenesis. J Investig Dermatol Symp Proc, 1, 97-1. |
42 | Martin G, Goh E, Neff AW (2002). Evaluation of the developmental toxicity of crocetin on Xenopus. Food Chem Toxicol, 40, 959-4. DOI |
43 | Martin SA, Lord CJ, Ashworth A (2010). Therapeutic Targeting of the DNA Mismatch Repair Pathway. Clin. Cancer Res, 16, 5107. DOI |
44 | Molnar J, Szabo D, Pusztai R, et al (2000). Membrane associated antitumor effects of crocine-, ginseniside-and cannabinoid derivates. Anticancer Res, 20, 861-7. |
45 | Morjani H, Tarantilis P, Polissiou M, et al (1990). Growth inhibition and induction of crythroid differentiation activity by crocin, dimethylcrocetine and carotene on K562 tumor cells. Anticancer Res, 10, 1398-6. |
46 | Nair SC, Salomi MJ, Pannikar. B, et al (1991). Modulatory effects of the extracts of saffron and Nigela sativa against cisplatinum induced toxicity in mice. J Ethnopharmacol, 31, 75-3. DOI |
47 | Morris GM, Goodsell DS, Halliday RS, et al (1998). Automated docking using a lamarckian genetic algorithm and and empirical binding free energy function. J Comput Chem, 19, 1639-62. DOI ScienceOn |
48 | Nair SC, Kurumboor SK, Hasegawa JH (1995). Saffron chemoprevention in biology and medicine: a review. Cancer Biother, 10, 257-4. DOI |
49 | Nair SC, Panikkar B, Panikkar KR (1991). Antitumor activity of saffron (Crocus sativus). Cancer Lett, 57, 109-14. DOI |
50 | Nair SC, Salomi MJ, Varghese CD, et al (1992). Effect of saffron on thymocute proliferation, intracellular gluthation levels and its antitumor activity. BioFactors, 1, 51-4. |
51 | Nair SC, Varghese CD, Pannikar KR, et al (1994). Effects of saffron on vitamin A levels and its antitumor activity on the growth of solid tumors in mice. Int J Pharmacog, 32, 105-14. DOI |
52 | Neckers L (2006). Chaperoning oncogenes: Hsp90 as a target of geldanamycin. Handb Exp Pharmacol, 172, 259-77. DOI |
53 | Oda Y, Tatsumi Y (1993). New lectins from bulbs of Crocus sativus. Biol Pharm Bull, 16, 978-1. DOI |
54 | Persidis A (1998). Proteomics: an ambitious drug development platform attempts to link gene sequence to expressed phenotype under various physiological states. Nat Biotechnol, 16, 393-4. DOI |
55 | Pons JL, Labesse G (2009). -TOME-2: a new pipeline for comparative modeling of protein-ligand complexes. Nucl Acids Res, 37, 485-91. DOI |
56 | Salomi MJ, Nair SC, Panikkar PR (1990). Inhibitory effects of Nigela sativa and saffron (Crocus sativus) on chemical carcinogenesis in mice and its non-mutagenic activity. Proc Ker Sci Congr, 3, 125-6. |
57 | Premkumar K, Abraham SK, Santhiya ST, et al (2001). Inhibition of genotoxicity by saffron (Crocus sativus L.) in mice. Drug Chem Toxicol, 24, 421-8. DOI |
58 | Reed JC (2003). Apoptosis-targeted therapies for cancer. Cancer Cell, 1, 17-2. |
59 | Salomi MJ, Nair SC, Panikkar PR (1991). Cytotoxicity and nonmutagenicity of Nigela sativa and saffron (Crocus sativus) in vitro. Proc Ker Sci Congr, 5, 244. |
60 | Salomi MJ, Nair SC, Panikkar PR (1991). Inhibitory effects of Nigela sativa and saffron (Crocus sativus) on chemical carcinogenesis in mice. Nutr Cancer, 16, 67-2. DOI |
61 | Smith TAD (1998). Carotenoids and cancer: prevention and potential therapy. Br J Biomed Sci, 55, 268-5. |
62 | Takashi I (1992). Antioxidative property of the anthraquinonepigment from the cultured cells of saffron, and enzymatic comparison between some cultured cells. Shokubutsu Soshiki Baiyo, 9, 51-3. |
63 | Tanaka T, De Luca LM (2009). Therapeutic Potential of "Rexinoids" in cancer prevention and treatment. Cancer Res, 69, 4945. DOI |
64 | Tang XH, Gudas LJ (2011). Retinoids-Retinoic Acid Receptors and Cancer. Annual Review of Pathology: Mechanisms of Disease, 6, 345-4. DOI |
65 | Tarantilis PA, Morjani H, Polissiou M, et al (1994). Inhibition of growth and induction of differentiation promyelocytic leukemia (HL-60) by carotenoids from Crocus sativus L. Anticancer Res, 14, 1913-8. |